203
Participants
Start Date
August 30, 2017
Primary Completion Date
February 1, 2021
Study Completion Date
March 30, 2023
BackBeat Moderato System
Eligible patients randomized after optimization phase to PHC ON for 12 months. Patients continue standard or modified anti-hypertension medical regime at discretion of the investigator
BackBeat Moderato Sytsem
Eligible patients randomized after optimization phase to PHC OFF for 12 months. Patients continue standard or modified anti-hypertension medical regime at discretion of the investigator.
UZ Brussel - Heart Rhythm Management Center, Brussels
Vilnius University Hospital Santariskiu Klinikos, Vilnius
Samodzielnym Publicznym Centralnym Szpitalem Klinicznym, Warsaw
Silesian Center for Heart Diseases, Zabrze
Lead Sponsor
Collaborators (1)
Massachusetts General Hospital
OTHER
MLM Medical Labs GmbH
INDUSTRY
nabios GmbH
UNKNOWN
BackBeat Medical Inc
INDUSTRY